Medical News

RSS

Seniors understand very little about health overhaul law, poll finds

The Hill: "The majority of the nation's seniors have little understanding of what the Democrats' newly enacted healthcare law actually does, according to poll results released Monday. The survey, sponsored by the National Council on Aging (NCOA), an advocate for seniors, found that only 17 percent of respondents could answer even half of the 12 questions about key provisions in the law selected by the NCOA.

28 Jul 2010

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.

28 Jul 2010

Calcium transfer impacts fuel mechanism for normal cell metabolism

University of Pennsylvania School of Medicine researchers have described a previously unknown biological mechanism in cells that prevents them from cannibalizing themselves for fuel. The mechanism involves the fuel used by cells under normal conditions and relies on an ongoing transfer of calcium between two cell components via an ion channel. Without this transfer, cells start consuming themselves as a way of to get enough energy.

28 Jul 2010

IntriCon second-quarter net sales increase 16.6% to $14.9 million

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical devices, today announced financial results for its second quarter ended June 30, 2010.

28 Jul 2010

Maryland sees savings in federal health law, for a while at least

Maryland could spend $829 million less than expected on health care between next year and 2020 because of the federal health overhaul law, according to an analysis by a state-convened committee, The Associated Press/Washington Post reports. "The savings, however, last only until the end of the decade, when the federal law shifts a greater share of financial responsibility for Medicaid expansion to the states." The analysis was produced by the state's Health Care Reform Coordinating Council, a panel created by Gov. Martin O'Malley in March (Witte, 7/26).

28 Jul 2010

Study shows music alleviates anxiety, depression

For decades research has shown that listening to music alleviates anxiety and depression, enhances mood, and can increase cognitive functioning, such as spatial awareness. However, until now, research has not addressed how we listen to music. For instance, is the cognitive benefit still the same if we listen to music whilst performing a task, rather than before it? Further, how does our preference for a particular type of music affect performance? A new study from Applied Cognitive Psychology shows that listening to music that one likes whilst performing a serial recall task does not help performance any more than listening to music one does not enjoy.

28 Jul 2010

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

Life sciences giant GE Healthcare has opened a $15 million medical technology manufacturing facility in Cardiff, Wales. The new facility is based at the 30-acre Maynard Centre, where the company already employs over 400 people.

28 Jul 2010

Antigenics announces positive results of AG-707 genital herpes vaccine

Antigenics announced positive results with AG-707, an investigational therapeutic vaccine being developed to treat herpes simplex virus-2,the virus that causes genital herpes, in infected patients. Developed by Antigenics, the vaccine triggers a cellular immune response, stimulating both CD4+ and CD8+ T cells.

28 Jul 2010

Industry still making sense of federal e-health regs

Health care industry players are still sorting out the latest regulations on an up-to-$36 billion federal program to encourage doctors and hospitals to use electronic medical records.

28 Jul 2010

InterMune second-quarter total revenue decreases to $5.9 million

InterMune, Inc. today announced results from operations for the second quarter and six months ended June 30, 2010. InterMune also highlighted its recent clinical development and business activities, and provided forward-looking financial guidance for 2010.

28 Jul 2010

FDA approves addition of 10 sites to WorldHeart's Levacor VAD BTT clinical study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that the United States Food and Drug Administration (FDA) has approved the addition of ten sites to the Levacor ventricular assist device (VAD) Bridge-to-Transplant (BTT) clinical study. WorldHeart's pivotal BTT study is now approved to enroll patients at 20 sites in the U.S.

28 Jul 2010

Advocacy group critiques patient debt load in Indiana

A new survey has sparked an Indiana patient advocacy group to say hospitals in the state should earn their nonprofit status by providing more low-cost charity care, The Indianapolis Star reports. "Armed with a survey that showed close to half of hospital patients going into debt to pay their bills, the Consumer Action Coalition Education Fund and Indiana Legal Services said hospitals are doing too little to inform people about alternative payment plans." Medical debt is a large problem in the city, said the study's author and the education fund director.

28 Jul 2010

Aflac second-quarter total revenues increase 15.5% to $5.0 billion

Reflecting the benefit from a stronger yen/dollar exchange rate and lower realized investment losses, total revenues rose 15.5% to $5.0 billion in the second quarter of 2010, compared with $4.3 billion in the second quarter of 2009. Net earnings were $581 million, or $1.23 per diluted share, compared with $314 million, or $.67 per share, a year ago.

28 Jul 2010

Scientists unveil new biomarkers for stroke, coronary heart disease

Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.

28 Jul 2010

Report: Generic drugs offer savings for Medicaid

A new report suggests that expanding use of generic drugs could offer significant savings for Medicaid.

28 Jul 2010

Research on method to open blood-brain barrier for safe cancer drug delivery

One of the human body's most powerful defensive tools, the blood-brain barrier is a chemical labyrinth that prevents toxins and viruses in the bloodstream from reaching the brain. This foolproof security system, however, limits the ability of physicians to deliver drugs directly to the brain, making it difficult to treat brain tumors. Researchers at Rensselaer Polytechnic Institute are endeavoring to solve this problem by investigating new methods for bypassing the blood-brain barrier and combating the spread of brain cancer.

28 Jul 2010

MabCure's MAbs 94% accurate in identifying ovarian cancer

Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.

28 Jul 2010

Scientists develop novel chemotherapeutic method for anticancer drug delivery

Combining nature and Greek mythology, researchers at the Technion-Israel Institute of Technology have developed a tiny "Trojan Horse" system for delivering cancer-fighting drugs. With this system, the drugs are delivered only once they are inside the cancerous cells, so there is no damage to the healthy cells in the surrounding area.

28 Jul 2010

Attaching transferrin to nanoparticle surface can kill cancer cells

A normally benign protein found in the human body appears to be able - when paired with nanoparticles - to zero in on and kill certain cancer cells, without having to also load those particles with chemotherapy drugs.The finding could lead to a new strategy for targeted cancer therapies, according to the University of North Carolina at Chapel Hill scientists who made the discovery.

28 Jul 2010

NSW school heaters to be replaced

Unflued gas heaters in public schools posed a risk of respiratory ailments to students, a report found. Education Minister Verity Firth announced yesterday that the NSW government will replace these heaters. The government funded study to look at the effects of these low-emission unflued gas heaters in NSW public schools found “no measurable adverse changes in lung function” but said it was important to seek “alternative, effective and efficient sources of domestic and public space heating that does not have adverse effects”.

27 Jul 2010